Markets
Intel
(Artur Widak/Getty Images)

Intel is on its best run since the ’87 crash

The stock is approaching its 200-day moving average.

Intel is continuing to pop. On Thursday, it was one of the top-performing stocks in the S&P 500, and at last glance the once dominant American chipmaker’s stock was up more than 27% over the last four days.

That’s Intel’s best four-day run since the aftermath of the 1987 stock market crash, after the stock has been repeatedly plumbing close to its lowest levels in a decade. That romp is close to pushing the stock price over its 200-day moving average, typically viewed as a sign that some significant momentum is in the offing.

Clearly, the market sniffs something in the wind. The company reported earnings at the end of January but that didn’t do much to catalyze the stock. Analysts have recently reported rumblings that the US government could be looking to orchestrate some sort of partnership between Intel and Taiwanese chip giant TSMC for an AI-related semiconductor undertaking. Perhaps.

But given how important the market seems to view politically connected stocks recently — we’ve repeatedly noted the outperformance of companies with ownership links to right-wing oligarchs with business and financial linkages to the Trump campaign and administration — it’s clear the market sees a government intervention as a more than welcome development for Intel after the atrocious run the stock has had over the past year, down nearly 60% before its recent run-up.

More Markets

See all Markets
markets

Gene-editing stocks rally on Bloomberg report that FDA plans to fast-track approval process

Shares of biotechs working with gene-editing treatments rose after the industry’s top regulator told Bloomberg News that the Food and Drug Administration plans to publish a paper in early November outlining the agency’s new, faster approach to approving those treatments.

markets

Getty Images shares moon on licensing deal with Perplexity

Getty Images soared Friday after announcing a multiyear licensing deal with AI search company Perplexity AI. Reuters reports:

Under the agreement, Perplexity will integrate Getty’s API technology into its AI platform workflows, enabling users to access premium visuals while improving image attribution. The collaboration is part of a wider trend of digital platforms signing licensing deals with AI content providers to expand content access while respecting intellectual property rights and generating revenue.

Getty was up as much as 85% in the premarket trading session, but those gains are quickly dropping as holders rush to dump the stock, which has been a truly disastrous long-term trade.

In fact, Getty has had a pretty bizarre ride since it returned to the public markets on July 25, 2022, as part of a SPAC deal — in a previous life it had been publicly traded before being taken private in 2008. Within days of its return, Getty became a minor meme stock, spiking more than 250% before crashing a couple months later.

Since then, the stock’s trajectory has been abysmal. Prior to the announcement of the Perplexity AI deal on Friday, it was down 80% from its trading debut. No wonder people are trying to get out fast.

At last glance, those 85% gains in the premarket have been swamped by sellers, shrinking today’s gain for Getty down to 17%.

markets

AbbVie earnings beat estimates but sag on decline in oncology and aesthetics biz

AbbVie slipped after it reported earnings results that beat Wall Street estimates, but also showed a slowdown in its oncology and aesthetics business.

The company reported adjusted quarterly earnings per share of $1.86, compared to the $1.77 analysts polled by FactSet were expecting, and raised its full-year profit guidance. It also reported revenue at $15.7 billion, higher than the $15.5 billion the Street was penciling in.

But the pharmaceutical giant’s oncology and aesthetics business (sales of Botox and Juvederm) slowed down and missed the Street’s estimates. The latter is sometimes seen as a pulse for consumer sentiment.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.